Suppr超能文献

罕见病、科学进展的趋势与挑战:巴西十年研究概况

Rare diseases, trends and challenges for scientific advances: a snapshot of a decade of research in Brazil.

作者信息

de Oliveira Aquino Fábio, da Silva Ricardo Eccard, Garbi Novaes Maria Rita Carvalho

机构信息

Universidade de Brasília, Brasil.

Agência Nacional de Vigilância Sanitária, Brasil.

出版信息

Concilium. 2024 Oct;24(19):126-144. Epub 2024 Sep 14.

Abstract

Brazil is home to around 13 million rare disease patients, which represents a significant challenge for biomedical research and public health. This descriptive and exploratory study analyzed research protocols on rare diseases submitted to Plataforma Brasil between 2013 and 2023, with the aim of identifying trends, challenges and opportunities for scientific progress in this area. The research evaluated variables such as the number of studies submitted and approved, sample characteristics, type of study, experimental design, research phase, participation in international networks, and epidemiological data (ICD). The results indicate a substantial increase in the number of protocols submitted over the period analyzed, with an average approval rate of 87.26%. Most of the studies were conducted in public institutions, highlighting the fundamental role of the public sector in rare disease research in Brazil. These findings suggest a growing investment and interest in research in this area, which could boost the development of new therapies and interventions, as well as supporting the formulation of more effective public policies to meet the needs of patients with rare diseases.

摘要

巴西约有1300万罕见病患者,这对生物医学研究和公共卫生构成了重大挑战。这项描述性和探索性研究分析了2013年至2023年间提交给巴西平台(Plataforma Brasil)的罕见病研究方案,旨在确定该领域科学进展的趋势、挑战和机遇。该研究评估了诸如提交和批准的研究数量、样本特征、研究类型、实验设计、研究阶段、参与国际网络情况以及流行病学数据(国际疾病分类)等变量。结果表明,在所分析的时间段内提交的方案数量大幅增加,平均批准率为87.26%。大多数研究在公共机构进行,凸显了公共部门在巴西罕见病研究中的基础性作用。这些发现表明对该领域研究的投资和兴趣不断增加,这可能会推动新疗法和干预措施的开发,并有助于制定更有效的公共政策以满足罕见病患者的需求。

相似文献

2
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
4
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Italian cancer figures, report 2012: Cancer in children and adolescents.
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
8
Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
Campbell Syst Rev. 2024 Jun 13;20(2):e1406. doi: 10.1002/cl2.1406. eCollection 2024 Jun.
9
Brazilian private health system: history, scenarios, and trends.
BMC Health Serv Res. 2022 Jan 10;22(1):49. doi: 10.1186/s12913-021-07376-2.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验